跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gugutams - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gugutams
Approved
STANDARD
Gugutams
Hanmi Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
dbc99b8c7239c42a
Company
Hanmi Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
dbc99b8c7239c42a
Drug Approval Philippines Name
Gugutams
Product Name
Gugutams
Registration Number
DR-XY48127
Brand Name
Gugutams
Generic Name
Tadalafil + Tamsulosin hydrochloride
Dosage Form
Capsule [contains one (1) Film-Coated Tadalafil and Tamsulosin HCl pellets]
Dosage Strength
5 mg/400 mcg
Manufacturer
Hanmi Pharmaceutical Co., Ltd.
Importer
JLT Pharma, Inc.
Company Detail Path
/organization/hanmi-pharmaceutical-co-ltd
Issuance Date
21 June 2022
Expiry Date
21 June 2027
Pharmacologic Category
Alpha-adrenoreceptor Antagonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
dbc99b8c7239c42a
Type
Standard
Back to Philippines FDA Approvals